Delivery Order SPE2DB22D3102-SPE2DB25FK9PH

Award Date 1/16/25
Potential Completion Date 2/7/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,974.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed-price pricing type, with a final completion date of February 27, 2025. The award is not designated under any set-aside program. It provides for the delivery of HYPERTET 250 UNIT/ML SYRINGE medical supplies, which are likely used for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.92 firm fixed-price delivery order contract is for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a specialty medical product. The contract has a period of performance through December 11, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,409.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The contract has an ultimate completion date of April 8, 2025 and is a Firm Fixed Price arrangement. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $1,057.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, designated as SPE2DX15D1120|SPE2DX25FCHMC, is a Delivery Order for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The contract has an ultimate completion date of May 9, 2025 and is a Firm Fixed Price arrangement. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a $11,628.54 firm fixed price delivery order for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,409.52 firm fixed-price delivery order is for the supply of "HYPERTET 250 UNIT/ML SYRINGEML" and has a completion date of June 12, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award with the identification number SPE2DB22D3301|SPE2DB25FY2QS was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,285.70 delivery order contract is for the supply of 4567794867 HYPERTET 250 UNIT/ML SYRINGEML and has a firm fixed price pricing type. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,662.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is for the supply of 4565532857 - HYPERTET 250 UNIT/ML...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $1,761.90. The contract has a firm-fixed-price pricing type and an ultimate completion date of July 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FQA48, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,057.14 firm fixed-price delivery order is for the supply of 4567690752 HYPERTET 250 UNIT/ML SYRINGEML medical products. The contract has an ultimate completion date of April 15, 2025 and was awarded on March 25, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9PH
    Delivery Order

This federal contract award, valued at $2,114.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of HYPERTET 250 UNIT/ML SYRINGEML, a medical product, with a period of performance through February 7, 2025.

The award is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/18/25, 1:49 AM